Source comparison
Receptor Mechanisms: Pulsatile vs Sustained GH Release
GHRP-6 Acetate (Growth Hormone Releasing Peptide-6) binds to the ghrelin receptor (GHS-R1a) on somatotroph cells in the anterior pituitary with high affinity but limited duration—plasma half-life is approximately 20–30 minutes, meaning receptor occupancy drops
This comparison does not assign a generated winner or score.
- GHRP-6 Acetate (Growth Hormone Releasing Peptide-6) binds to the ghrelin receptor (GHS-R1a) on somatotroph cells in the anterior pituitary with high affinity but limited duration—plasma half-life is approximately 20–30 minutes, meaning receptor occupancy drops rapidly after administration. This produces a sharp GH pulse that mirrors endogenous secretion patterns: GH levels rise 5–15 times above baseline within 30 minutes, peak around 60 minutes, and return to baseline within 3–6 hours. The hypothalamus detects this pulse and responds with somatostatin release, which inhibits further GH secretion until the next endogenous pulse cycle. GHRP-6 Acetate does not suppress natural GH pulsatility—it amplifies existing pulses when timed correctly.
- MK-677 (ibutamoren) is a non-peptide ghrelin mimetic with a plasma half-life of 4–6 hours and tissue-level effects lasting 24 hours due to sustained receptor activation. Unlike GHRP-6 Acetate, MK-677 does not produce discrete pulses. It creates a pharmacological elevation of baseline GH that persists throughout the day and night, increasing mean 24-hour GH levels by 60–70% and IGF-1 levels by 40–90% depending on dose. This sustained elevation overrides natural pulsatility—the hypothalamus cannot suppress secretion because receptor activation is continuous, not pulsatile. Research models studying circadian GH dynamics or feedback loop sensitivity cannot use MK-677 without confounding the variable they are measuring.
- Here's what we've learned from peptide research design: if your protocol examines acute anabolic signaling, nutrient partitioning windows, or downstream pathway activation that depends on GH pulse amplitude, GHRP-6 Acetate is the only compound that preserves the physiological context your model requires. If your protocol measures cumulative IGF-1-mediated effects over weeks—collagen synthesis, bone mineral density changes, lipolytic rate shifts—MK-677 provides stable exposure without the dosing frequency burden that injectable peptides impose.